Announcements Trials
Browse Landscape

Phase

Phase 2 84Phase 1 31Phase 3 28Phase 1/2 19Phase 4 5Phase NA 3Phase 2/3 3Phase EARLY_PHASE1 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Carcinoma, Renal Cell 1

Interventions

Magnetic Resonance Spectroscopy 9gallium 68 PSMA-11 7Specimen Handling 42-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 4enzalutamide 2bicalutamide 2acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2Standard of Care 2Radiation 2Positron Emission Tomography Computed Tomography 2HhAntag691 2Abiraterone Acetate 268Ga-DKFZ-PSMA-11 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2xentuzumab 1trastuzumab biosimilar HLX02 1tislelizumab 1teprotumumab 1tazemetostat 1relugolix 1pertuzumab 1palbociclib 1olaparib 1niraparib 1gallium citrate 1eribulin 1entrectinib 1darolutamide 1cobimetinib 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Prostatic Neoplasms × enzalutamide × Clear all
NCT05683964 2026-02-13

Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

Beth Israel Deaconess Medical Center

Phase EARLY_PHASE1 Active not recruiting
9 enrolled
Genitourinary

Prostatic Neoplasms

NCT03734653 2025-11-06

Testosterone Therapy in Castration Resistant Prostate Cancer

University of Colorado, Denver

Phase EARLY_PHASE1 Completed
30 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡